Discover 1,024 paid clinical trials in Saint Paul, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,024
DG1 Spectacle Lens for Myopia Progression Control in Children
for
Myopia
Location: Medina MN, Chicago IL, Powell OH, Granville OH,
Sponsor: HOYA Lens Thailand LTD.
Sex: All
Age: 7 - 10
Code: NCT06781931
Recruiting
Glaucoma Laser Assessment of Stability and Sustainability
for
Glaucoma
Location: Coon Rapids MN
Sponsor: Twin Cities Eye Consultants
Sex: All
Age: 40+
Code: NCT06963684
Recruiting
Non- vs Partial Controlled Weightbearing After Multiple Knee Ligament Reconstruction
for
Knee Injuries
Location: Edina MN
Sponsor: Twin Cities Orthopedics
Sex: All
Age: 14 - 59
Code: NCT05073276
Recruiting
Full Vs Partial Weightbearing During the First Six Weeks of Rehab. After Fibular Collateral Ligament Reconstruction
for
Knee Injuries
Location: Edina MN
Sponsor: Twin Cities Orthopedics
Sex: All
Age: 14 - 59
Code: NCT05073263
Recruiting
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
for
Breast Cancer, Metastatic
Location: Saint Louis Park MN, Rochester MN, Omaha NE, Zion IL,
Sponsor: ALX Oncology Inc.
Sex: All
Age: 18+
Code: NCT07007559
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
for
Type 1 Diabetes Mellitus
Location: Saint Louis Park MN, Rochester MN, Kansas City MO,
Sponsor: Sanofi
Sex: All
Age: 1 - 25
Code: NCT07088068
Phase 3, Recruiting
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
for
Heart Failure
Location: Minneapolis MN, Milwaukee WI, Peoria IL,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06033950
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
for
Focal Segmental Glomerulosclerosis,
Location: Edina MN, Hinsdale IL, Chicago IL, Ann Arbor MI, London,